SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-025314
Filing Date
2012-01-26
Accepted
2012-01-26 17:06:38
Documents
6
Period of Report
2012-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d288397d8k.htm 8-K 21543
2 UNDERWRITING AGREEMENT d288397dex11.htm EX-1.1 126993
3 OPINION OF COOLEY LLP d288397dex51.htm EX-5.1 6011
4 PRESS RELEASE DATED JANUARY 25, 2012 d288397dex991.htm EX-99.1 7836
5 PRESS RELEASE DATED JANUARY 26, 2012 d288397dex992.htm EX-99.2 8212
6 GRAPHIC g288397g10i36.jpg GRAPHIC 28956
  Complete submission text file 0001193125-12-025314.txt   211744
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 12548397
SIC: 2834 Pharmaceutical Preparations